March 10, 2020 / 8:38 PM / 25 days ago

BRIEF-Constellation Pharmaceuticals Announces Q4 Loss Per Share $0.69

March 10 (Reuters) - Constellation Pharmaceuticals Inc :

* CONSTELLATION PHARMACEUTICALS ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.69

* Q4 EARNINGS PER SHARE ESTIMATE $-0.69 — REFINITIV IBES DATA

* CONSTELLATION PHARMACEUTICALS SEES CURRENT CASH, CASH EQUIVALENTS & MARKETABLE SECURITIES WILL ENABLE CO TO FUND OPERATIONS INTO H22022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below